Inhibition of human T-cell responses by allergen peptides (Q34567734)

3 August 2017

1 reference

title

Inhibition of human T-cell responses by allergen peptides (English)

1 reference

3 August 2017

M Larché

1

1 reference

3 August 2017

1 December 2001

1 reference

3 August 2017

1 reference

3 August 2017

104

1 reference

3 August 2017

4

1 reference

3 August 2017

377-382

1 reference

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Structure of the human class I histocompatibility antigen, HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Effects of peptide therapy on ex vivo T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

The safety and efficacy of ALLERVAX CAT in cat allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Immunotherapy of allergy: anergy, deletion, and immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease.

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1783330

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

27 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2001.01293.X

Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects

21 January 2018

1 reference

12 December 2020

Treatment of cat allergy with T-cell reactive peptides

1 reference

12 December 2020

Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects

1 reference

12 December 2020

Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats

1 reference

12 December 2020

Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin

1 reference

12 December 2020

Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells

1 reference

12 December 2020

Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice

1 reference

12 December 2020

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

12 December 2020

Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin

1 reference

12 December 2020

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

12 December 2020

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

1 reference

12 December 2020

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

1 reference

12 December 2020

10.1046/J.1365-2567.2001.01293.X

Identifiers

DOI

1 reference

release_kwjurt4wqrgchhaw5tcewecoda

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kwjurt4wqrgchhaw5tcewecoda

24 November 2022

mapped directly with Wikidata item

0 references

1 reference

PubMed ID

11899422